Your browser doesn't support javascript.
loading
Neutropenia management and granulocyte colony-stimulating factor use in patients with solid tumours receiving myelotoxic chemotherapy--findings from clinical practice.
Krzemieniecki, K; Sevelda, P; Erdkamp, F; Smakal, M; Schwenkglenks, M; Puertas, J; Trojan, A; Szabo, Z; Bendall, K; Maenpaa, J.
Affiliation
  • Krzemieniecki K; Oncology Department, University Hospital, Sniadeckich 10, Krakow, 31-531, Poland, krzemieniecki@plusnet.pl.
Support Care Cancer ; 22(3): 667-77, 2014 Mar.
Article in En | MEDLINE | ID: mdl-24154740

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Breast Neoplasms / Granulocyte Colony-Stimulating Factor / Febrile Neutropenia / Lung Neoplasms / Antineoplastic Agents Type of study: Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Support Care Cancer Journal subject: NEOPLASIAS / SERVICOS DE SAUDE Year: 2014 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Breast Neoplasms / Granulocyte Colony-Stimulating Factor / Febrile Neutropenia / Lung Neoplasms / Antineoplastic Agents Type of study: Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Support Care Cancer Journal subject: NEOPLASIAS / SERVICOS DE SAUDE Year: 2014 Type: Article